Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Clinical Carbetocin Myocardium Trial Part 2
NCT03899961Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Apr 2019
- Primary completion
- Mar 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of carbetocin in pregnancy complications (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Plasma Concentration Troponin I at 8 hours. Started Apr 2019; status: completed.
02
Drugs
carbetocin
03
Conditions
pregnancy complications
Beyond the preview
Go deeper on NCT03899961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899961.